Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer

References

• Peery TM. The new and old diseases: a study of mortality trends in the United States, 1900–1969 Ward Burdick award address. Am J Clin Pathol. 1975;63(4):453–474. doi:10.1093/ajcp/63.4.4531091134
   PubMed Web of Science ®Google Scholar
• Wingo PA, Cardinez CJ, Landis SH, et al. Long-term trends in cancer mortality in the United States, 1930–1998. Cancer. 2003;97(S12):3133–3275. doi:10.1002/cncr.1138012784323
   PubMed Web of Science ®Google Scholar
• Balakrishnan M, George R, Sharma A, Graham DY. Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep. 2017;19(8). doi:10.1007/s11894-017-0575-8
   Google Scholar
• Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–648. doi:10.1016/s0140-6736(20)31288-532861308
   PubMed Web of Science ®Google Scholar
• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. doi:10.3322/caac.2120824399786
   PubMed Web of Science ®Google Scholar
• Munro AJ. Comparative cancer survival in European countries. Br Med Bull. 2014;110(1):5–22. doi:10.1093/bmb/ldu00924816203
   PubMed Web of Science ®Google Scholar
• Etemadi A, Safiri S, Sepanlou SG, et al. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):42–54. doi:10.1016/s2468-1253(19)30328-031648970
   PubMed Web of Science ®Google Scholar
• Suh YS, Yang HK. Screening and early detection of gastric cancer: east versus west. Surg Clin North Am. 2015;95(5):1053–1066. doi:10.1016/j.suc.2015.05.01226315523
   PubMed Web of Science ®Google Scholar
• Riihimaki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget. 2016;7(32):52307–52316. doi:10.18632/oncotarget.1074027447571
   PubMedGoogle Scholar
• Marghalani AM, Bin Salman TO, Faqeeh FJ, Asiri MK, Kabel AM. Gastric carcinoma: insights into risk factors, methods of diagnosis, possible lines of management, and the role of primary care. J Family Med Prim Care. 2020;9(2659–2663). doi:10.4103/jfmpc.jfmpc_527_20
   Google Scholar
• Shenoy S. CDH1 (E-Cadherin) mutation and gastric cancer: genetics, molecular mechanisms and guidelines for management. Cancer Manag Res. 2019;11(10477):10477–10486. doi:10.2147/cmar.S20881831853199
   PubMed Web of Science ®Google Scholar
• Kharazmi E, Babaei M, Fallah M, et al. Importance of tumor location and histology in familial risk of upper gastrointestinal cancers: a nationwide cohort study. Clin Epidemiol. 2018;10(1169):1169–1179. doi:10.2147/clep.S16815230233251
   PubMed Web of Science ®Google Scholar
• Møller P, Seppälä TT, Bernstein I, et al. Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the prospective lynch syndrome database. Gut. 2018;67(7):1306–1316. doi:10.1136/gutjnl-2017-31405728754778
   PubMed Web of Science ®Google Scholar
• Marwitz T, Hüneburg R, Spier I, et al. Hereditary diffuse gastric cancer: a Comparative Cohort Study according to pathogenic variant status. Cancers. 2020;12(12):3726. doi:10.3390/cancers12123726
   Web of Science ®Google Scholar
• Zhu Z, Fu H, Wang S, et al. Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer. Ann Transl Med. 2020;8(22):1484. doi:10.21037/atm-20-662033313229
   PubMed Web of Science ®Google Scholar
• Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol. 2020;5(52):52. doi:10.21037/tgh.2020.01.0233073047
   PubMed Web of Science ®Google Scholar
• Slavin TP, Weitzel JN, Neuhausen SL, et al. Genetics of gastric cancer: what do we know about the genetic risks? Transl Gastroenterol Hepatol. 2019;4(4):55. doi:10.21037/tgh.2019.07.0231463414
   PubMed Web of Science ®Google Scholar
• Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol. 2013;10(5):289–301. doi:10.1038/nrclinonc.2013.4123529000
   PubMed Web of Science ®Google Scholar
• Chen T, Fallah M, Jansen L, et al. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. Cancer Lett. 2015;369(1):152–166. doi:10.1016/j.canlet.2015.08.01426319898
   PubMed Web of Science ®Google Scholar
• Liu H, Hemminki K, Sundquist J, et al. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects. Cancer Med. 2013;2(5):718–724. doi:10.1002/cam4.11624403237
   PubMed Web of Science ®Google Scholar
• Morais S, Antunes L, Bento MJ, Lunet N. Risk of second primary cancers among patients with a first primary gastric cancer: a population-based study in North Portugal. Cancer Epidemiol. 2017;50(85):85–91. doi:10.1016/j.canep.2017.08.00728843176
   PubMed Web of Science ®Google Scholar
• Morais S, Antunes L, Bento MJ, Lunet N. Second primary gastric cancers in a region with an overall high risk of gastric cancer. Gac Sanit. 2020;34(4):393–398. doi:10.1016/j.gaceta.2018.08.01030527910
   PubMed Web of Science ®Google Scholar
• Ji J, Hemminki K. Second gastric cancers among patients with primary sporadic and familial cancers in Sweden. Gut. 2006;55(6):896–898. doi:10.1136/gut.2005.090118
   Web of Science ®Google Scholar
• Chen SC, Liu C-J, Hu Y-W, et al. Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan. Gastric Cancer. 2016;19(2):490–497. doi:10.1007/s10120-015-0482-325772342
   PubMed Web of Science ®Google Scholar
• Pukkala E, Engholm G, Højsgaard Schmidt LK, et al. Nordic cancer Registries - an overview of their procedures and data comparability. Acta Oncol. 2018;57(4):440–455. doi:10.1080/0284186x.2017.140703929226751
   PubMed Web of Science ®Google Scholar
• Engholm G, Ferlay J, Christensen N, et al. NORDCAN–a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725–736. doi:10.3109/0284186100378201720491528
   PubMed Web of Science ®Google Scholar
• Meyer LA, Broaddus RR, Lu KH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control. 2009;16(1):14–22. doi:10.1177/10732748090160010319078925
   PubMed Web of Science ®Google Scholar
• Ryan NAJ, Morris J, Green K, et al. Association of mismatch repair mutation with age at cancer onset in lynch syndrome: implications for stratified surveillance strategies. JAMA Oncol. 2017;3(12):1702. doi:10.1001/jamaoncol.2017.061928772289
   PubMed Web of Science ®Google Scholar
• Birkeland S, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964–1986. Int J Cancer. 1995;60(2):183–189. doi:10.1002/ijc.29106002097829213
   PubMed Web of Science ®Google Scholar
• Hortlund M, Arroyo Mühr LS, Storm H, et al. Cancer risks after solid organ transplantation and after long-term dialysis. Int J Cancer. 2017;140(5):1091–1101. doi:10.1002/ijc.3053127870055
   PubMed Web of Science ®Google Scholar
• Rama I, Grinyo JM. Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol. 2010;6(9):511–519. doi:10.1038/nrneph.2010.10220736984
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Sud A, Zheng G, et al. Second primary cancers in non-Hodgkin lymphoma: bi-directional analyses suggesting role for immune dysfunction. Int J Cancer. 2018;143(10):2449–2457. doi:10.1002/ijc.3180130238973
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Hemminki A, Försti A, et al. Second primary cancers in patients with invasive and in situ squamous cell skin carcinoma, Kaposi sarcoma and Merkel cell carcinoma: role for immune mechanisms? J Invest Dermatol. 2020;140(1):48–55.e1. doi:10.1016/j.jid.2019.04.03131288011
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Zheng G, Sud A, et al. Second primary cancers in non-Hodgkin lymphoma: family history and survival. Int J Cancer. 2020;146(970–976). doi:10.1002/ijc.32391
   Web of Science ®Google Scholar
• Mullangi S, Lekkala MR. StatPearls (StatPearls PublishingCopyright © 2020). StatPearls Publishing LLC; 2020.
   Google Scholar
• Matysiak-Budnik T, Jamet P, Ruskoné-Fourmestraux A, et al. Gastric MALT lymphoma in a population-based study in France: clinical features, treatments and survival. Aliment Pharmacol Ther. 2019;50(6):654–663. doi:10.1111/apt.1540931347731
   PubMed Web of Science ®Google Scholar
• Palmela C, Fonseca C, Faria R, et al. Increased risk for metachronous gastric adenocarcinoma following gastric MALT lymphoma-A US population-based study. United European Gastroenterol J. 2017;5(4):473–478. doi:10.1177/2050640616671643
   Web of Science ®Google Scholar
• Frödin J-E, Ericsson J, Barlow L. Multiple primary malignant tumors in a national cancer registry: reliability of reporting. Acta Oncol. 1997;36(5):465–469. doi:10.3109/028418697090013009292741
   PubMed Web of Science ®Google Scholar
• Blair VR, McLeod M, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020;21(8):e386–e397. doi:10.1016/s1470-2045(20)30219-932758476
   PubMed Web of Science ®Google Scholar
• Zheng G, Hemminki A, Försti A, et al. Second primary cancer after female breast cancer: familial risks and cause of death. Cancer Med. 2019;8(1):400–407. doi:10.1002/cam4.189930479046
   PubMed Web of Science ®Google Scholar
• Zheng G, Chattopadhyay S, Forsti A, Sundquist K, Hemminki K. Familial risks of second primary cancers and mortality in ovarian cancer patients. Clin Epidemiol. 2018;10(1457):1457–1466. doi:10.2147/clep.S17417330349393
   PubMed Web of Science ®Google Scholar